Home › Leukemia › Oklahoma › Oklahoma City
Leukemia clinical trials in Oklahoma City, OK
4 studies for Leukemia are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RecruitingObservational study
- University of Oklahoma Health Sciences Center, Oklahoma City
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- OU Health Stephenson Cancer Center, Oklahoma City
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- OU Health Stephenson Cancer Center, Oklahoma City
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Oklahoma City
- Non-Small Cell Lung Cancer32 studies
- Ovarian Cancer29 studies
- Endometrial Cancer28 studies
- Colorectal Cancer22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Breast Cancer18 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Cancer (all types)15 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Bladder Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.